Literature DB >> 19143563

Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo.

Thomas A Russo1, Ulrike MacDonald, Janet M Beanan, Ruth Olson, Ian J MacDonald, Shauna L Sauberan, Nicole R Luke, L Wayne Schultz, Timothy C Umland.   

Abstract

BACKGROUND: Acinetobacter baumannii is a bacterial pathogen of increasing medical importance. Little is known about genes important for its survival in vivo. METHODS AND
RESULTS: Screening of random transposon mutants of the model pathogen AB307-0294 identified the mutant AB307.27. AB307.27 contained its transposon insertion in pbpG, which encodes the putative low-molecular-mass penicillin-binding protein 7/8 (PBP-7/8). AB307.27 was significantly killed in ascites (P<.001), but its growth in Luria-Bertani broth was similar to that of its parent, AB307-0294 (P=.13). The survival of AB307.27 was significantly decreased in a rat soft-tissue infection model (P<.001) and a rat pneumonia model (P=.002), compared with AB307-0294. AB307.27 was significantly killed in 90% human serum in vitro, compared with AB307-0294 (P<.001). Electron microscopy demonstrated more coccobacillary forms of AB307.27, compared with AB307-0294, suggesting a possible modulation in the peptidoglycan, which may affect susceptibility to host defense factors.
CONCLUSIONS: These findings demonstrate that PBP-7/8 contributes to the pathogenesis of A. baumannii. PBP-7/8 either directly or indirectly contributes to the resistance of AB307-0294 to complement-mediated bactericidal activity. An understanding of how PBP-7/8 contributes to serum resistance will lend insight into the role of this low-molecular-mass PBP whose function is poorly understood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143563     DOI: 10.1086/596317

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

1.  Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection.

Authors:  Brittany L Mortensen; Eric P Skaar
Journal:  Cell Microbiol       Date:  2012-06-14       Impact factor: 3.715

2.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  Crystal structure of 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase from the ESKAPE pathogen Acinetobacter baumannii.

Authors:  Kristin A Sutton; Jennifer Breen; Thomas A Russo; L Wayne Schultz; Timothy C Umland
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-02-16       Impact factor: 1.056

4.  Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

Authors:  D K Pomakova; C-B Hsiao; J M Beanan; R Olson; U MacDonald; Y Keynan; T A Russo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-15       Impact factor: 3.267

Review 5.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

6.  Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology.

Authors:  Xenia Kostoulias; Gerald L Murray; Gustavo M Cerqueira; Jason B Kong; Farkad Bantun; Eleftherios Mylonakis; Chen Ai Khoo; Anton Y Peleg
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

7.  Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance.

Authors:  Jessica M Breslow; Joseph J Meissler; Rebecca R Hartzell; Phillip B Spence; Allan Truant; John Gaughan; Toby K Eisenstein
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

8.  The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.

Authors:  Shun Xin Wang-Lin; Ruth Olson; Janet M Beanan; Ulrike MacDonald; Joseph P Balthasar; Thomas A Russo
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

9.  The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain.

Authors:  A Pérez; M Merino; S Rumbo-Feal; L Álvarez-Fraga; J A Vallejo; A Beceiro; E J Ohneck; J Mateos; P Fernández-Puente; L A Actis; M Poza; G Bou
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

10.  A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.

Authors:  Greg Harris; Rhonda Kuo Lee; Christopher K Lam; Gregory Kanzaki; Girishchandra B Patel; H Howard Xu; Wangxue Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.